Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
This Summer, Barbie Is Everywhere. Should You Buy Mattel Stock?
Action dramas typically dominate the summer movie season and are represented this year by Indiana Jones and the Dial of Destiny and the newest entry
Benchmark Reiterates Schneider National Inc – Class B (SNDR) Buy Recommendation
Fintel reports that on July 6, 2023, Benchmark reiterated coverage of Schneider National Inc – Class B (NYSE:SNDR) with a Buy recommendation. Analyst Price Forecast
Top Stocks To Buy Now? 3 Healthcare Stocks To Know
The healthcare industry, which is responsible for the development, manufacture, and distribution of medical products and services, is a critical sector of the economy. Healthcare
Better Buy: Allegiant Travel vs. Sun Country Airlines
According to the International Air Transport Association (IATA), the insatiable demand for air travel we saw last year has persisted in 2023. And the trend
Needham Maintains Merus N.V. (MRUS) Buy Recommendation
Fintel reports that on April 14, 2023, Needham maintained coverage of Merus N.V. (NASDAQ:MRUS) with a Buy recommendation. Analyst Price Forecast Suggests 76.80% Upside As
Got $1,000? 3 Stocks to Buy Now While They’re on Sale.
A thousand bucks may not be a life-changing amount of money. But if it’s cash you know you won’t be needing for a while, then
HC Wainwright & Co. Maintains Arcadia Biosciences (RKDA) Buy Recommendation
Fintel reports that on April 14, 2023, HC Wainwright & Co. maintained coverage of Arcadia Biosciences (NASDAQ:RKDA) with a Buy recommendation. Analyst Price Forecast Suggests
Tigress Financial Reiterates Dolby Laboratories (DLB) Buy Recommendation
Fintel reports that on April 14, 2023, Tigress Financial reiterated coverage of Dolby Laboratories (NYSE:DLB) with a Buy recommendation. Analyst Price Forecast Suggests 7.32% Upside
Goldman Sachs Maintains DLocal (DLO) Buy Recommendation
Fintel reports that on April 13, 2023, Goldman Sachs maintained coverage of DLocal (NASDAQ:DLO) with a Buy recommendation. Analyst Price Forecast Suggests 32.19% Upside As
Canaccord Genuity Initiates Coverage of Intellia Therapeutics (NTLA) with Buy Recommendation
Fintel reports that on April 13, 2023, Canaccord Genuity initiated coverage of Intellia Therapeutics (NASDAQ:NTLA) with a Buy recommendation. Analyst Price Forecast Suggests 181.05% Upside